| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.07 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |